Occurrence and toxicological assessment of selected active pharmaceutical ingredients in effluents of pharmaceutical manufacturing plants and wastewater treatment plants in Kampala, Uganda

There is an increasing eco-toxicological risk associated with pharmaceuticals globally. The prevalence of six active pharmaceutical ingredients (APIs) was studied in effluents of three pharmaceutical manufacturing plants (PMPs) and two wastewater treatment plants (WWTPs) in Kampala, Uganda to ascert...

Full description

Bibliographic Details
Published in:	Water Practice and Technology
Main Authors:	R. Kayiwa, H. Kasedde, M. Lubwama, J. B. Kirabira, Timothy Kayondo
Format:	Article
Language:	English
Published:	IWA Publishing 2022-04-01
Subjects:	active pharmaceutical ingredients pharmaceutical manufacturing plants prevalence risk assessment wastewater treatment plants
Online Access:	http://wpt.iwaponline.com/content/17/4/852

Similar Items

Review of Medicinal Plants and Active Pharmaceutical Ingredients against Aquatic Pathogenic Viruses
by: Wenyu Liao, et al.
Published: (2022-06-01)

THE MANUFACTURING OF PHARMACEUTICAL INGREDIENTS IN RUSSIAN FEDERATION: THE CRISIS AT THE TURN OF XX TO XXI CENTURIES
by: E. V. Denisova
Published: (2019-01-01)

Continuous-Flow Chemistry and Photochemistry for Manufacturing of Active Pharmaceutical Ingredients
by: Pavlína Horáková, et al.
Published: (2022-12-01)

Editorial: Medicinal chemistry of active pharmaceutical ingredients of drug products
by: Mohd Imran, et al.
Published: (2024-04-01)

Active pharmaceutical ingredients in dermatological medicines of Ukrainian pharmaceutical market
by: I. O. Vlasenko, et al.
Published: (2019-03-01)

THE USE OF PLANTS FOR PURIFICATION OF WASTEWATER FROM PHARMACEUTICAL FACTORIES
by: Liubov Kika, et al.
Published: (2023-12-01)

Brazilian national production of active pharmaceutical ingredients: regulatory and strategic framework
by: MARLON DANIEL L. TONINI, et al.
Published: (2023-12-01)

Ionic Liquids as Tools to Incorporate Pharmaceutical Ingredients into Biopolymer-Based Drug Delivery Systems
by: Paula Berton, et al.
Published: (2023-02-01)

Improving the Physicochemical and Biopharmaceutical Properties of Active Pharmaceutical Ingredients Derived from Traditional Chinese Medicine through Cocrystal Engineering
by: Danyingzi Guan, et al.
Published: (2021-12-01)

An improved procedure for synthesis of lenalidomide as an active pharmaceutical ingredient
by: Elaheh Ataollahi, et al.
Published: (2025-09-01)

Bioremediation Kinetics of Pharmaceutical Industrial Effluent
by: M. Šabić, et al.
Published: (2015-05-01)

Simple, Accurate and Multianalyte Determination of Thirteen Active Pharmaceutical Ingredients in Polypills by HPLC-DAD
by: Barbara Żuromska-Witek, et al.
Published: (2022-12-01)

Miniaturization in action: High-resolution, low-cost analytical platforms for biomedical and pharmaceutical research
by: Erika Maria Ricci, et al.
Published: (2025-12-01)

Binary Mixtures of Some Active Pharmaceutical Ingredients with Fatty Alcohols—The Criteria of Successful Eutectic Formation and Dissolution Improvement
by: Songhee Jin, et al.
Published: (2020-11-01)

Identification and determination of selected hormones and pharmaceuticals in municipal wastewater treatment plant effluent, soil, and crops
by: Neda Mirikaram, et al.
Published: (2022-09-01)

Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases
by: V. Vanhoorne, et al.
Published: (2019-08-01)

Effective removal of selected pharmaceuticals from sewerage treatment plant effluent using natural clay (Na-montmorillonite)
by: Senar Aydin, et al.
Published: (2023-05-01)

Modification of the Physicochemical Properties of Active Pharmaceutical Ingredients via Lyophilization
by: Amir Taldaev, et al.
Published: (2023-11-01)

Natural deep eutectic solvents for turbidity removal from synthetic pharmaceutical wastewater
by: Hayyan Adeeb, et al.
Published: (2024-01-01)

Pervaporation-assisted crystallization of active pharmaceutical ingredients (APIs)
by: Claire Schmitz, et al.
Published: (2023-01-01)

Low removal of acidic and hydrophilic pharmaceutical products by various types of municipal wastewater treatment plants
by: Christian Gagnon, et al.
Published: (2012-03-01)

In-Depth Understanding of the Impact of Material Properties on the Performance of Jet Milling of Active Pharmaceutical Ingredients
by: Viktor Bultereys, et al.
Published: (2025-09-01)

Flavonoid-containing copolymers can act as both extended-release excipients and active pharmaceutical ingredients for the treatment of diabetes
by: Shicui Luo, et al.
Published: (2025-10-01)

DEVELOPMENT AND VALIDATION OF METHOD OF QUANTITATIVE DETERMINATION OF RESIDUAL ORGANIC SOLVENTS IN INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENT WITH GC-FID
by: E. V. Butina, et al.
Published: (2019-01-01)

Promoting local production and active pharmaceutical ingredient (API) industry in low and middle income countries (LMICs): impact on medicines access and policy
by: Muhammad Akhtar Abbas Khan, et al.
Published: (2024-12-01)

Methodological approach to the pharmaceutical development of solutions for injection in polymer packaging
by: V. О. Shevchenko, et al.
Published: (2022-12-01)

Evaluating wastewater surveillance for estimating pharmaceutical use
by: Gilbert Osena, et al.
Published: (2025-10-01)

Dynamics of Pharmaceuticals in the Soil–Plant System: A Case Study on Mycorrhizal Artichoke
by: Francesco De Mastro, et al.
Published: (2025-05-01)

Ginsenoside Re as a Probe for Evaluating the Catalytic Potential of Microcrystalline Cellulose for the Degradation of Active Pharmaceutical Ingredients
by: Xinyu Gao, et al.
Published: (2025-06-01)

Design Space Identification and Visualization for Continuous Pharmaceutical Manufacturing
by: Samir Diab, et al.
Published: (2020-03-01)

Pharmaceuticals Removal from Wastewater with Microalgae: A Pilot Study
by: André Pereira, et al.
Published: (2023-05-01)

Transferring Crystallization Conditions from Small to Larger Scale for Achieving Targeted Crystal Morphologies of an Active Pharmaceutical Ingredient
by: Nicolás Antonio Ramos Ojeda, et al.
Published: (2023-12-01)

Pharmaceutical advances: Integrating artificial intelligence in QSAR, combinatorial and green chemistry practices
by: Baljit Singh, et al.
Published: (2024-10-01)

Non-pharmaceutical hypercholesterolemia management by plant stanol-enriched product consumption
by: N. V. Perova
Published: (2006-10-01)

Evaluation of Ionic Liquids and Ionic Liquids Active Pharmaceutical Ingredients Inhibition in Elastase Enzyme Activity
by: Fátima A. R. Mota, et al.
Published: (2021-01-01)

Pharmaceutical Pollution and Disposal of Expired, Unused, and Unwanted Medicines in the Brazilian Context
by: Letícia de Araújo Almeida Freitas, et al.
Published: (2021-05-01)

The remote provision of pharmaceutical products and services by retail pharmacies in Kampala, Uganda; practices and challenges
by: Ibrahim Ali Fauzi, et al.
Published: (2024-09-01)

Monitoring Pharmaceuticals and Personal Care Products in Healthcare Effluent Wastewater Samples and the Effectiveness of Drug Removal in Wastewater Treatment Plants Using the UHPLC-MS/MS Method
by: Lucia Molnarova, et al.
Published: (2024-03-01)

A Review of Pharmaceutical Nano-Cocrystals: A Novel Strategy to Improve the Chemical and Physical Properties for Poorly Soluble Drugs
by: Jianbing Tan, et al.
Published: (2021-04-01)

A GENERAL OVERVIEW OF THE ROMANIAN PHARMACEUTICAL MARKET
by: ȘTELIAC NELA
Published: (2015-04-01)